Literature DB >> 29929639

Medium-Term Follow-Up of Early Leaflet Thrombosis After Transcatheter Aortic Valve Replacement.

Philipp Ruile1, Jan Minners2, Philipp Breitbart2, Simon Schoechlin2, Michael Gick2, Gregor Pache3, Franz-Josef Neumann2, Manuel Hein2.   

Abstract

OBJECTIVES: The aim of this study was to investigate medium-term outcomes in patients with leaflet thrombosis (LT).
BACKGROUND: The clinical significance of early LT after transcatheter aortic valve replacement, diagnosed by computed tomography angiography in approximately 10% of patients, is uncertain.
METHODS: In this observational study, computed tomographic angiography was performed a median of 5 days after transcatheter aortic valve replacement and assessed for evidence of LT. Follow-up consisted of clinical visits, telephone contact, or questionnaire.
RESULTS: LT was diagnosed in 120 of 754 patients (15.9%). Patients with LT were less likely male (36.7% vs. 47.0%, p = 0.045), with a lower rate of atrial fibrillation (28.3% vs. 41.5%, p = 0.008). Peri- and post-procedural characteristics were comparable between groups (e.g., valve implantation technique; p = 0.116). During a median follow-up period of 406 days, there were no significant differences in the primary endpoint of all-cause mortality and the secondary combined endpoint of stroke and transient ischemic attack between patients with LT and those without LT (18-month Kaplan-Meier estimate for mortality 86.6% vs. 85.4%, p = 0.912; for stroke- or transient ischemic attack-free survival 98.5% vs. 96.8%, p = 0.331). In univariate and multivariate analyses, LT was not predictive of either endpoint, whereas male sex (p = 0.03), atrial fibrillation (p = 0.002), and more than mild paravalvular leak (p = 0.015) were associated with all-cause mortality.
CONCLUSIONS: In this prospective observational cohort undergoing post-transcatheter aortic valve replacement computed tomographic angiography, LT was not associated with increased mortality or rates of stroke over a follow-up period of 406 days.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  follow-up; leaflet thrombosis; post-TAVR CTA; transcatheter aortic valve replacement

Mesh:

Year:  2018        PMID: 29929639     DOI: 10.1016/j.jcin.2018.04.006

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  9 in total

1.  Haemodynamic prosthetic valve performance in patients with early leaflet thrombosis after transcatheter aortic valve implantation.

Authors:  Manuel Hein; Jan Minners; Nikolaus Jander; Philipp Breitbart; Christian Stratz; Gregor Pache; Franz-Josef Neumann; Philipp Ruile
Journal:  Clin Res Cardiol       Date:  2019-02-06       Impact factor: 5.460

Review 2.  Transcatheter Aortic Valve Leaflet Thrombosis: Prevalence, Management, and Future Directions.

Authors:  Makoto Nakashima; Hasan Jilaihawi
Journal:  Curr Cardiol Rep       Date:  2021-11-11       Impact factor: 2.931

Review 3.  Platelets: Implications in Aortic Valve Stenosis and Bioprosthetic Valve Dysfunction From Pathophysiology to Clinical Care.

Authors:  Stephanie L Sellers; Gaurav S Gulsin; Devyn Zaminski; Rong Bing; Azeem Latib; Janarthanan Sathananthan; Philippe Pibarot; Rihab Bouchareb
Journal:  JACC Basic Transl Sci       Date:  2021-11-17

4.  Subclinical leaflet thrombosis after transcatheter aortic valve implantation: no association with left ventricular reverse remodeling at 1-year follow-up.

Authors:  Jurrien H Kuneman; Gurpreet K Singh; Nicolaj C Hansson; Laura Fusini; Steen H Poulsen; Federico Fortuni; E Mara Vollema; Anders L D Pedersen; Andrea D Annoni; Bjarne L Nørgaard; Gianluca Pontone; Nina Ajmone Marsan; Victoria Delgado; Jeroen J Bax; Juhani Knuuti
Journal:  Int J Cardiovasc Imaging       Date:  2021-10-16       Impact factor: 2.357

5.  Performance of Computed Tomography Angiography (CTA) for the Diagnosis of Hypo-Attenuated Leaflet Thickening (HALT).

Authors:  Manuel Hein; Philipp Breitbart; Jan Minners; Philipp Blanke; Simon Schoechlin; Christopher Schlett; Tobias Krauss; Martin Soschynski; Franz-Josef Neumann; Philipp Ruile
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

6.  Impact of leaflet thrombosis on hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A meta-analysis.

Authors:  Zixin Tian; Tiejun Li; Shumei Ma
Journal:  Clin Cardiol       Date:  2020-01-20       Impact factor: 2.882

Review 7.  Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?

Authors:  Liesbeth Rosseel; Ole De Backer; Lars Søndergaard
Journal:  Front Cardiovasc Med       Date:  2019-04-18

8.  Analysis and Study on the Quality of Life of Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Guoliang Wu; Jiajun Zhu; Kaixuan Hu; Huan Cai; Xiaomei Li; Yining Yang
Journal:  Comput Math Methods Med       Date:  2021-12-16       Impact factor: 2.238

Review 9.  Leaflet immobility and thrombosis in transcatheter aortic valve replacement.

Authors:  Arnold C T Ng; David R Holmes; Michael J Mack; Victoria Delgado; Raj Makkar; Philipp Blanke; Jonathon A Leipsic; Martin B Leon; Jeroen J Bax
Journal:  Eur Heart J       Date:  2020-09-01       Impact factor: 35.855

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.